1. Establishment of a Tumour–Stroma Airway Model (OncoCilAir) to Accelerate the Development of Human Therapies against Lung Cancer. Issue 5 (October 2016) Authors: Mas, Christophe; Boda, Bernadett; Futy, Mireille Caul; Huang, Song; Wisniewski, Ludovic; Constant, Samuel Journal: ATLA Issue: Volume 44:Issue 5(2016) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health state dependent multiphoton induced autofluorescence in human 3D in vitro lung cancer model. Issue 1 (December 2017) Authors: Kilin, Vasyl; Mas, Christophe; Constant, Samuel; Wolf, Jean-Pierre; Bonacina, Luigi Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Health state dependent multiphoton induced autofluorescence in human 3D in vitro lung cancer model. Issue 1 (December 2017) Authors: Kilin, Vasyl; Mas, Christophe; Constant, Samuel; Wolf, Jean-Pierre; Bonacina, Luigi Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein. Issue 54 (4th October 2019) Authors: De Matos, Raphaël; Vuilleumier, Jérémy; Mas, Christophe; Constant, Samuel; Staedler, Davide; Gerber-Lemaire, Sandrine Journal: RSC advances Issue: Volume 9:Issue 54(2019) Page Start: 31659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Genetic engineering of a 3D in vitro human airway model sensitive to carcinogens. (20th October 2017) Authors: Benainous, Hugo; Huang, Song; Wiszniewski, Ludovic; Constant, Samuel; Mas, Christophe Journal: Toxicology letters Issue: Volume 280(2017)Supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer. Issue 10 (20th August 2014) Authors: Melotti, Alice; Mas, Christophe; Kuciak, Monika; Lorente‐Trigos, Aiala; Borges, Isabel; Ruiz i Altaba, Ariel Journal: EMBO molecular medicine Issue: Volume 6:Issue 10(2014:Oct.) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗